Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
FTC
Cross-Governmental RFI Seeking Input on Private Equity in Health Care
On March 5, 2024, several federal agencies issued a Request for Information (RFI) requesting public comments on deals that are…
FTC Challenges More than 100 Patents in the FDA Orange Book
Recently, the United States Federal Trade Commission (FTC) sent letters to medical device companies and drugmakers disputing the…
FTC Reaches Anti-Trust Settlement with Surescripts
Recently, the United States Federal Trade Commission (FTC) announced a settlement with Surescripts over the company’s alleged use…
FTC Deepens Probe into Pharmacy Benefit Managers
Recently, the United States Federal Trade Commission (FTC) announced that it would expand its probe into pharmacy benefit managers…
FTC Proposes Amendments to the Health Breach Notification Rule
Recently, the United States Federal Trade Commission (FTC) announced proposed amendments to modernize and strengthen the Health…
Policy and Medicine Compliance Update June 2023 Issue Features Update on…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
AMGA Opposes FTC Non-Compete Clause Rule
AMGA recently sent a letter to the Federal Trade Commission (FTC) regarding the agency’s proposed Non-Compete Clause Rule,…
GoodRx Fined in First Violation of the Health Breach Notification Rule
The United States Federal Trade Commission (FTC) filed a proposed order with the Department of Justice (DOJ) regarding GoodRx…
Groups Ask FTC to Investigate GPOs
A handful of advocacy groups – including the American Economic Liberties Project, Center for Economic and Policy Research, Demand…
Policy and Medicine Compliance Update October, 2022 Issue Covers HHS Self…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…